263 related articles for article (PubMed ID: 21326158)
1. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
Cela I; Miller IJ; Katz RS; Rizman A; Shammo JM
Clin Adv Hematol Oncol; 2010 Nov; 8(11):806-9. PubMed ID: 21326158
[No Abstract] [Full Text] [Related]
2. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G
J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983
[No Abstract] [Full Text] [Related]
3. Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.
Scheinberg P; Singulane CC; Barbosa LS; Scheinberg M
Clin Rheumatol; 2014 Sep; 33(9):1347-9. PubMed ID: 24740463
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin-receptor agonist as a treatment of thrombocytopenia associated with systemic lupus erythematosus.
Moreno Martínez MJ; Gallego P; Moreno Ramos MJ
Reumatol Clin; 2016; 12(1):57. PubMed ID: 26024588
[No Abstract] [Full Text] [Related]
5. Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists.
Lown R; Rhodes E; Bosworth J; Shannon MS; Stasi R
Clin Adv Hematol Oncol; 2010 Nov; 8(11):809-12. PubMed ID: 21326159
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.
Lusa A; Carlson A
Lupus; 2018 Sep; 27(10):1723-1728. PubMed ID: 29673280
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
Maroun MC; Ososki R; Andersen JC; Dhar JP
Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag in thrombocytopenia.
Zimmer J; Hentges F; Andrès E
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
[No Abstract] [Full Text] [Related]
9. Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
Haselboeck J; Kaider A; Pabinger I; Panzer S
Thromb Haemost; 2013 Apr; 109(4):676-83. PubMed ID: 23389750
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for chronic immune thrombocytopenia.
Milosevic I; Slade E; Drysdale H;
Lancet; 2016 Jan; 387(10016):336. PubMed ID: 26842445
[No Abstract] [Full Text] [Related]
11. Eltrombopag for chronic immune thrombocytopenia - Authors' reply.
Grainger JD;
Lancet; 2016 Jan; 387(10016):336-337. PubMed ID: 26842444
[No Abstract] [Full Text] [Related]
12. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Modi Y; Shaaban H; Gauchan D; Maroules M
J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
Leng Q; Wang W; Wang Y; Wu L
J Clin Pharm Ther; 2021 Apr; 46(2):532-538. PubMed ID: 33277725
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.
Tian H; Kong D; Li Y; Gu C; Yu Z; Wang Z; Wu D; Yin J
Platelets; 2022 Aug; 33(6):951-953. PubMed ID: 34915800
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag in systemic lupus erythematosus with antiphospholipid syndrome: thrombotic events.
Boulon C; Vircoulon M; Constans J
Lupus; 2016 Mar; 25(3):331. PubMed ID: 26405023
[No Abstract] [Full Text] [Related]
16. Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Trautmann K; Jakob C; von Grünhagen U; Schleyer E; Brümmendorf TH; Siegert G; Ehninger G; Platzbecker U
Thromb Haemost; 2012 Aug; 108(2):397-8. PubMed ID: 22739569
[No Abstract] [Full Text] [Related]
17. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
18. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Gauchan D; Shaaban H; Gedeon D; Maroules M
Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
[No Abstract] [Full Text] [Related]
19. Immune thrombocytopenic purpura--from agony to agonist.
Schwartz RS
N Engl J Med; 2007 Nov; 357(22):2299-301. PubMed ID: 18046034
[No Abstract] [Full Text] [Related]
20. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura.
Nurden AT; Viallard JF; Nurden P
Lancet; 2009 May; 373(9674):1562-9. PubMed ID: 19324405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]